H&HN August 15, 2017
Karyn Hede

After years of fanfare and a few false starts, the era of genomic medicine has finally arrived.

Across the country, thousands of patients are being treated, or having their treatment changed, based on information gleaned from their genome. It’s a revolution that has been promised since the human genome was first published in 2001. But making it real required advances in information technology infrastructure and a precipitous drop in price.

Today, the cost of whole exome sequencing, which reveals the entire protein-coding portion of DNA, is now roughly equivalent to an MRI exam in many parts of the country, says Louanne Hudgins, M.D., president of the American College of Medical Genetics and Genomics and director of perinatal genetics at Lucile...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Health IT, Health System / Hospital, Healthcare System, Patient / Consumer, Payer, Physician, Population Health Mgmt, Primary care, Provider
Why is healthcare so bad at cybersecurity?
Price transparency divides hospitals, CMS
The Download: what’s next for AI, and stem-cell therapies
Hospitals poised for better year in 2025, but system remains fragile
Strengthening Medicaid and Tribal Relationships to Better Support Native Populations-

Share This Article